Study of Mental Care in Spain

This study has been completed.

First Received on January 15, 2009. Last Updated on September 10, 2009 History of Changes

Sponsor:	AstraZeneca
Information provided by:	AstraZeneca
ClinicalTrials.gov Identifier:	NCT00824031

Purpose

Non-interventional, multicenter, cross-sectional study to evaluate the mental care received by schizophrenic patients and their caregivers in Spain irrespective of the drug prescribed.

Condition
Schizophrenia

Study Type:	Observational
Study Design:	Time Perspective: Cross-Sectional
Official Title:	Study of Mental Care in Spain

Resource links provided by NLM:

MedlinePlus related topics: Caregivers Schizophrenia

U.S. FDA Resources

Further study details as provided by AstraZeneca:

Primary Outcome Measures:

Camberwell's scale of Needs Analysis (CAN) [ Time Frame: Once ] [ Designated as safety issue: No ]
Caregiver Needs Questionnaire(CNF) [ Time Frame: Once ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Health of the Nation Outcome Scales (HoNOS) [ Time Frame: Once ]

Enrollment:	76
Study Start Date:	January 2009
Study Completion Date:	July 2009

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patient aged 18-year old or older who has been diagnosed as schizophrenia

Criteria

Inclusion Criteria:

Schizophrenia (DSM-IV criteria)
Attended to the mental care units for the first time in 2006

Exclusion Criteria:

Participation in another clinical trial
Other criteria that according to the medical criteria make difficult the normal development of the study

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00824031

Locations

Spain
Research Site
Ferrol, A Coruna, Spain
Research Site
Aviles, Asturias, Spain
Research Site
Jerez de la Frontera, Cadiz, Spain
Research Site
Torrejon de Ardoz, Castellon, Spain
Research Site
La Plana, Valencia, Spain
Research Site
Bilbao, Vizcaya, Spain
Research Site
Cordoba, Spain
Research Site
Girona, Spain
Research Site
Madrid, Spain

Sponsors and Collaborators

AstraZeneca

Investigators

Study Chair:	Manuel Gomez-Beneyto	University of Valencia
Study Chair:	Alberto Gonzalez	Hospital Universitario Principe de Asturias

More Information

No publications provided

Responsible Party:	Esteban Medina. Epidemiology Specialist, AstraZeneca Pharmaceutical
ClinicalTrials.gov Identifier:	NCT00824031 History of Changes
Other Study ID Numbers:	NIS-NES-DUM-2008/4
Study First Received:	January 15, 2009
Last Updated:	September 10, 2009
Health Authority:	Spain: Comité Ético de Investigación Clínica

Keywords provided by AstraZeneca:

schizophrenia
medical mental care
caregiver
Sapin

Additional relevant MeSH terms:

Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on February 09, 2012